On May 23, 2022, Harry Alcorn, Jr., Pharm.D., Senior Vice President of Clinical Operations of DiaMedica Therapeutics Inc. (the "Company"), resigned as an officer and employee of the Company and its subsidiaries, effective immediately. In connection with Dr. Alcorn's resignation and pursuant to the terms of his employment agreement with DiaMedica USA Inc. ("DiaMedica USA"), Dr. Alcorn and DiaMedica USA entered into a separation agreement ("Separation Agreement") on May 23, 2022.